BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact
Home » stem cells » Page 2

How iPSCs are Becoming an Emerging Area of Stem Cell Research

April 11, 2018 By Cade Hildreth (CEO) Leave a Comment

How iPS Cells are becoming an Emerging Area of Stem Cell Research - Depositphotos_102309082_m-2015

Since the discovery of induced pluripotent stem cells (iPSCs) in 2006, a large and diverse market for iPSC research tools has emerged. Included below is a ten-year history of iPSC grants (source: RePORT.NIH.gov), clinical trials (source: ClinicalTrials.gov), and scientific publications (source: PubMed.gov).

Both graphs below reveal the iPSC market is expanding. [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: Cellular Dynamics International, Coriell Institute for Medical Research, iPSCs, regenerative medicine, ReproCELL, stem cells

BioStem Technologies Inc. Announces Engagement of Dr. Felix Amon for Pharmaceutical Business Development

March 14, 2018 By Cade Hildreth (CEO) Leave a Comment

Pompano Beach, FL, March 13, 2018 — BioStem Technologies, Inc. (OTC: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a focus in Pharmaceuticals and Regenerative Medicine, announced today the addition of Dr. Felix Amon, who will consult BSEM with Pharmaceutical Business Development.
[Read more…]

Filed Under: Press Releases, Stem Cells Tagged With: stem cells

Definitive Guide To Perinatal Stem Cells

August 23, 2017 By Cade Hildreth (CEO) Leave a Comment

Perinatal stem cells are those derived right before or after birth. They include those derived from the umbilical cord blood and tissue, placental blood and tissue, and the amniotic tissue and amniotic fluid.

What are Perinatal Stem Cells?

However, when stem cells were first identified, only two types of stem cells were described, adult stem cells and embryonic stem cells. The reason a diverse range of stem cell types now exist is that human embryonic stem cells (hESCs) have become further characterized, the diversity of adult stem cell types has substantially expanded and induced pluripotent stem cells (iPSCs) have since been discovered.

Now, researchers debate the number of stem cells in existence, because the number depends on whether stem cells are characterized functionally (for example, neural stem cells, mesenchymal stem cells, and hematopoietic stem cells) or characterized by source tissue (for example, cord blood stem cells, dental pulp stem cells, and amniotic stem cells).

What is clear is that a wide range of stem cell types now exists, which has added substantial complexity to the stem cell landscape.
[Read more…]

Filed Under: Stem Cells Tagged With: embryonic, perinatal stem cells, post-natal, pre-natal, stem cells

Major Milestone for Stem Cells – 300K Scientific Publications

August 23, 2017 By Cade Hildreth (CEO) Leave a Comment

Stem Cell Milestone

Wow, this is a big moment for the stem cell community. We officially crossed 300,000 stem cell publications released to PubMed.gov.

PubMed is a service of the U.S. National Library of Medicine and NIH that comprises more than 27 million citations for biomedical literature.[1] It is the largest and comprehensive global database that exists for scientific publications. [Read more…]

Filed Under: Stem Cell News, Stem Cells Tagged With: scientific publications, stem cells

Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient

August 7, 2017 By Cade Hildreth (CEO) Leave a Comment

Biostage 1st patient treated

Procedure was approved via the FDA’s single-use expanded access program and was performed at a major U.S. hospital.

Biostage LogoHOLLISTON, Mass., Aug. 7, 2017 /PRNewswire/ — Biostage Inc., (Nasdaq: BSTG), (“Biostage” or the “Company”), a biotechnology company developing bioengineered organ implants to treat cancer, congenital abnormalities and other life-threatening conditions of the esophagus, bronchus and trachea, today announced the use of Biostage’s Cellspan Esophageal Implant product candidate in a patient at a major U.S. hospital via an FDA-approved single-use expanded access application.

[Read more…]

Filed Under: Stem Cells Tagged With: Biostage, Cellspan, organ implants, stem cells

  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 28
  • Next Page »

Nanocellect

Marathon Products

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram
Menu
  • Blog
  • Stem Cell News
    • Press Releases
  • Stem Cells
    • HSCs
    • iPS Cells
    • MSCs
    • Neural Stem Cells
    • Adipose SCs
  • Exosomes
  • Cell Therapy
    • CAR-T
  • Cord Blood
  • Interviews

Cart

Top Rated Products

  • Job Posting on BioInformant Job Posting on BioInformant.com - Your Perfect Hire Is In Our Audience
    Rated 0 out of 5
    $297
  • U.S. Cord Blood Banking Survey Cord Blood Banking Survey of U.S. Parents [2017]
    Rated 0 out of 5
    $197
  • Exosome Companies 2020 Global Database of Exosome Companies
    Rated 0 out of 5
    $149 $97
My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: Info@BioInformant.com | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.